Antipsychotics and COVID-19: the debate goes on - Authors' reply

Lancet Psychiatry. 2021 Dec;8(12):1030-1031. doi: 10.1016/S2215-0366(21)00428-4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antipsychotic Agents*
  • COVID-19*
  • Humans
  • SARS-CoV-2

Substances

  • Antipsychotic Agents